Perampanel

Perampanel, sold under the brand name Fycompa, is an anti-epileptic medication developed by Eisai Co. that is used in addition to other drugs to treat partial seizures and generalized tonic-clonic seizures for people older than twelve years.[4] It was first approved in 2012, and as of 2016[update], its optimal role in the treatment of epilepsy relative to other drugs was not clear.[6] It was the first antiepileptic drug in the class of selective... [wikipedia]